Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/137187
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Aldeguer,Xavier | en_US |
| dc.contributor.author | Carpio, Daniel | en_US |
| dc.contributor.author | Ginard,Daniel | en_US |
| dc.contributor.author | Marín, Ignacio | en_US |
| dc.contributor.author | Muñoz, Fernando | en_US |
| dc.contributor.author | Bastida, Guillermo | en_US |
| dc.contributor.author | Ceballos Santos, Daniel Sebastián | en_US |
| dc.contributor.author | González-Lama, Yago | en_US |
| dc.contributor.author | Menchén,Luis | en_US |
| dc.contributor.author | Ricart, Elena | en_US |
| dc.date.accessioned | 2025-04-23T13:49:58Z | - |
| dc.date.available | 2025-04-23T13:49:58Z | - |
| dc.date.issued | 2021 | en_US |
| dc.identifier.isbn | 978-84-7867-835-8 | en_US |
| dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/137187 | - |
| dc.language | spa | en_US |
| dc.publisher | Ferring España | en_US |
| dc.subject | 32 Ciencias médicas | en_US |
| dc.subject | 320503 Gastroenterología | en_US |
| dc.subject | 3209 Farmacología | en_US |
| dc.title | Optimización del uso de mesalazina en la colitis ulcerosa leve a moderada: de la evidencia a la experiencia | en_US |
| dc.type | info:eu-repo/semantics/book | en_US |
| dc.type | Book | en_US |
| dc.investigacion | Ciencias de la Salud | en_US |
| dc.type2 | Libro | en_US |
| dc.utils.revision | Sí | en_US |
| dc.identifier.ulpgc | Sí | en_US |
| dc.contributor.buulpgc | BU-MED | en_US |
| item.fulltext | Sin texto completo | - |
| item.grantfulltext | none | - |
| crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
| crisitem.author.orcid | 0000-0003-2384-4524 | - |
| crisitem.author.fullName | Ceballos Santos, Daniel Sebastián | - |
| Appears in Collections: | Libro | |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.